Children's Hospital of Philadelphia

Thank you for visiting CHOP vectors at ASGCT!

• More than 50 active clinical trials • More than 80 investigators engaged in basic and translational research • 20+ unique clinical and pre-clinical programs • A leader in providing 11 licensed cell and gene therapies • Treated more than 120 patients from 15 countries with in vivo gene therapies • Bench to bedside-enabling infrastructure, from vector manufacturing to navigating FDA regulatory process to clinical trials

Brands: For Clinical Vector Core inquiries: Dr. Van der loo at: For Research Vector Core inquiries: Xueyuan Liu at: